Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 07, 2024 16:05 ET
ICU Medical Announces First Quarter 2024 Results
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First quarter 2024...
May 07, 2024 16:05 ET
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today reported financial results for the first quarter ended March...
May 07, 2024 16:05 ET
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2024
InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE),...
May 07, 2024 16:05 ET
Intapp Announces Third Quarter Fiscal Year 2024 Financial Results
Intapp, Inc. (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, announced financial results for its third quarter ended March 31, 2024. Intapp also provided its outlook...
May 07, 2024 16:05 ET
Inuvo Reports 44% Year-Over-Year Revenue Growth to $17.0 Million for the First Quarter of 2024
Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, powered by artificial intelligence (AI) that serves brands and agencies, today provided a business update, and announced its financial results for the first quarter...
May 07, 2024 16:05 ET
Key Tronic Corporation Announces Results For the Third Quarter of Fiscal Year 2024
Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its results for the quarter ended March 30, 2024. For the third quarter of fiscal year 2024, Key Tronic reported total revenue of $140.5...
May 07, 2024 16:05 ET
Latham Group, Inc. Reports First Quarter 2024 Financial Results
Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced financial results for the first quarter 2024 ended March 30,...
May 07, 2024 16:05 ET
Lesaka to acquire leading payment platform Adumo welcoming new shareholders Apis and ARC
Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka”) has signed a definitive agreement to acquire Adumo RF (Pty) Ltd (“Adumo”) for ZAR 1.59 billion ($85.9 million translated at the prevailing rate $1: ZAR 18.50 as of May 7, 2024). The...
May 07, 2024 16:05 ET
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced that members of its senior management team will participate in the...
May 07, 2024 16:05 ET
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and innovative...
May 07, 2024 16:05 ET
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its first quarter ended March 31, 2024 and reiterated its previously issued outlook on business performance for the...
May 07, 2024 16:05 ET
Nature’s Sunshine Reports Strong First Quarter 2024 Results
Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the first quarter ended March 31, 2024....
May 07, 2024 16:05 ET
Ocular Therapeutix™ Reports First Quarter 2024 Results
Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related...
May 07, 2024 16:05 ET
ODDITY Tech Reports Record First Quarter Results, Raises Outlook
ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the first quarter ended March 31, 2024. “We delivered our most important quarter of the year with outstanding revenue growth and profitability,” said Oran Holtzman, ODDITY...
May 07, 2024 16:05 ET
Open Lending Reports First Quarter 2024 Financial Results
Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial results for its first quarter of 2024. “I am...
May 07, 2024 16:05 ET
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select assets of...
May 07, 2024 16:05 ET
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for its QIAcuity digital PCR devices that will...
May 07, 2024 16:05 ET
ResMed Announces Participation in the RBCCM Global Healthcare Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez, Chief Medical Officer, and Amy Wakeham, Chief Investor Relations Officer, will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024,...
May 07, 2024 16:05 ET
scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that...
May 07, 2024 16:05 ET
SIGA Reports Financial Results for Three Months Ended March 31, 2024
SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2024. “SIGA delivered strong results in the first quarter, with product revenues of $24...